AkzoNobel, Axalta get week to address UK regulator concerns over $25 billion merger

By Reuters News

- Dulux paint maker AkzoNobel AKZO.AS and US peer Axalta's AXTA.N $25 billion merger raises competition concerns in the UK vehicle refinish coatings market, Britain's competition watchdog said on Wednesday, giving them a week to offer remedies or face a deeper probe.

The companies announced the deal in November last year as part of a wave of consolidation in the sector, which faces rising costs and uncertainties created by US tariffs.

The Competition and Markets Authority found in its initial probe that the merger would create a clear UK market leader in vehicle refinish coatings, the paints used by repair centres and bodyshops to fix and repaint damaged vehicles, with a combined share of 40% to 50% of supply.

The regulator said the two companies compete closely in the UK, offering similar products, technical support and holding extensive vehicle manufacturer and insurer approvals, and that losing one could lead to higher prices or reduced quality and support for customers.

The CMA gave the companies until November 18 to offer remedies or face an in-depth Phase 2 investigation.

AkzoNobel and Axalta aim to address the CMA's concerns with the same remedy proposal that was included in the European Commission decision, the companies said in a statement, reiterating that they remain confident of completing the merger by early 2027.

The companies secured approval for the merger from the European Union last week after AkzoNobel agreed to sell its vehicle refinish coatings business in Europe and the UK to address the regulator's competition concerns.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.